Current status and prospects of personalized medicine in patients with inflammatory bowel disease
Review articleGastroent Hepatol 2026; 80(1): 44–48. doi: 10.48095/ccgh202644
SummaryLiteraturepdf Milan LukášGastroent Hepatol 2026; 80(1): 44–48. doi: 10.48095/ccgh202644
SummaryLiteraturepdf Milan Lukáš